Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
1.810
-0.290 (-13.81%)
At close: Apr 25, 2025, 4:00 PM
1.720
-0.090 (-4.97%)
After-hours: Apr 25, 2025, 4:05 PM EDT
Mangoceuticals Revenue
In the year 2024, Mangoceuticals had annual revenue of $615.87K, down -15.81%. Mangoceuticals had revenue of $105.25K in the quarter ending December 31, 2024, a decrease of -56.93%.
Revenue (ttm)
$615.87K
Revenue Growth
-15.81%
P/S Ratio
5.82
Revenue / Employee
$205,291
Employees
3
Market Cap
11.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
Dec 31, 2022 | 8.94K | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 21 hours ago - ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 23 hours ago - Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - GlobeNewsWire
- 3 days ago - CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Accesswire
- 2 months ago - Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - GlobeNewsWire
- 4 months ago - Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewsWire
- 6 months ago - MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - GlobeNewsWire
- 6 months ago - Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Newsfile Corp
- 7 months ago - MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN - GlobeNewsWire